JDRF Centers bring together projects linked by a central theme with the aim of testing a clinical outcome during the life of the center. JDRF places special value on proposals that uniquely bring together researchers from diverse but relevant fields to develop innovative approaches for treatment and prevention of type 1 Diabetes and its complications. Currently, JDRF supports the following centers in each program area:

Beta Cell Therapies:

Immune Therapies:

JDRF Autoimmunity Center Consortium (ACC):

Complications Therapies:

  • JDRF Center for the Study of Complications in Diabetes at Albert Einstein College of Medicine / University of Heidelberg / Baker International Diabetes Institute
  • JDRF Center for the Study of Complications in Diabetes at the University of Michigan

Glucose Control:

  • JDRF Center for the Study of Hypoglycemia at Yale

Partnerships: